Idrs Labs Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 15-11-2024
- Paid Up Capital ₹ 3.12 M
as on 15-11-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.03 Cr
as on 15-11-2024
- Revenue 95.10%
(FY 2024)
- Profit 184.02%
(FY 2024)
- Ebitda 761.97%
(FY 2024)
- Net Worth 15717.97%
(FY 2024)
- Total Assets 33.22%
(FY 2024)
About Idrs Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.12 M.
The company currently has active open charges totaling ₹10.03 Cr.
Yogesh Bhandari, Mahendra Joshi, and Shivkumar Madki serve as directors at the Company.
- CIN/LLPIN
U74900KA2012PTC080472
- Company No.
080472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2012
- Date of AGM
19 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Idrs Labs Private Limited offer?
Idrs Labs Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Computer & Mobile Apps Development, Application Development Service.
Who are the key members and board of directors at Idrs Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Bhandari  | Director | 01-May-2013 | Current |
| Shivkumar Madki | Director | 01-May-2013 | Current |
| Mahendra Joshi | Director | 01-May-2013 | Current |
Financial Performance of Idrs Labs.
Idrs Labs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 95.1% increase. The company also saw a substantial improvement in profitability, with a 184.02% increase in profit. The company's net worth Soared by an impressive increase of 15717.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Idrs Labs?
Unlock access to Idrs Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Oct 2020 | ₹1.67 M | Open |
Others Creation Date: 31 Oct 2019 | ₹8.82 M | Open |
Others Creation Date: 14 Jun 2018 | ₹2.40 Cr | Open |
How Many Employees Work at Idrs Labs?
Idrs Labs has a workforce of 58 employees as of Sep 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Idrs Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Idrs Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
